Bayer’s BlueRock Moves Parkinson’s Cell Therapy into Phase III

 
• By Kevin Grogan
  
Deep brain stimulation surgery for Parkinson's disease
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Therapy Areas